Home 5 Articles 5 23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition

23andMe Goes Public While the Clock Ticks on Illumina’s Grail Acquisition

M&A deal making in the diagnostics space remained hot and heavy in June. Key deals included Danaher’s announced $9.6 billion acquisition of life sciences plasma DNA maker Aldevron and the closing of Hologic’s acquisition of Finnish molecular infectious disease test firm Mobidiag for $795 million. But the big story was the closing of previously announced […]

M&A deal making in the diagnostics space remained hot and heavy in June. Key deals included Danaher’s announced $9.6 billion acquisition of life sciences plasma DNA maker Aldevron and the closing of Hologic’s acquisition of Finnish molecular infectious disease test firm Mobidiag for $795 million. But the big story was the closing of previously announced…

This content is for Paid Members only.
Login Register